{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T06:00:13Z","timestamp":1777788013672,"version":"3.51.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["ND\/DBT\/19\/026"],"award-info":[{"award-number":["ND\/DBT\/19\/026"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["- DBT\/JRF\/BET-16\/I\/2016\/AL\/99\\u2013487"],"award-info":[{"award-number":["- DBT\/JRF\/BET-16\/I\/2016\/AL\/99\\u2013487"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.molimm.2023.12.006","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T20:06:24Z","timestamp":1703707584000},"page":"55-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Recombinant human scFv antibody fragments against phospholipase A2 from Naja naja and Echis carinatus snake venoms: In vivo neutralization and mechanistic insights"],"prefix":"10.1016","volume":"165","author":[{"given":"Amit","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid Kamal","family":"Madni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivam","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinakar M.","family":"Salunke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2023.12.006_bib1","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/980250","article-title":"scFv antibody: principles and clinical application","volume":"2012","author":"Ahmad","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.molimm.2023.12.006_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67654-7","article-title":"An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies","volume":"10","author":"Ahmadi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molimm.2023.12.006_bib3","article-title":"Snake antivenom: Challenges and alternate approaches","volume":"181","author":"Alangode","year":"2020","journal-title":"Biochem. Pharmacol., Pharmacol. Ther. Potential Venom. Pept."},{"key":"10.1016\/j.molimm.2023.12.006_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8314","article-title":"Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite","volume":"12","author":"Albulescu","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molimm.2023.12.006_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19981-6","article-title":"A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite","volume":"11","author":"Albulescu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2023.12.006_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00848","article-title":"A Decoy-Receptor Approach Using Nicotinic Acetylcholine Receptor Mimics Reveals Their Potential as Novel Therapeutics Against Neurotoxic Snakebite","volume":"10","author":"Albulescu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.molimm.2023.12.006_bib7","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.str.2017.08.011","article-title":"Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability","volume":"25","author":"Arimori","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.molimm.2023.12.006_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/antib8020028","article-title":"David vs. Goliath: the structure, function, and clinical prospects of antibody fragments","volume":"8","author":"Bates","year":"2019","journal-title":"Antibodies"},{"key":"10.1016\/j.molimm.2023.12.006_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxcx.2020.100048","article-title":"Comparative proteomics of geographically distinct saw-scaled viper (Echis carinatus) venoms from India","volume":"7","author":"Bhatia","year":"2020","journal-title":"Toxicon X"},{"key":"10.1016\/j.molimm.2023.12.006_bib10","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tips.2020.05.006","article-title":"Causes and Consequences of Snake Venom Variation","volume":"41","author":"Casewell","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.molimm.2023.12.006_bib11","doi-asserted-by":"crossref","first-page":"9205","DOI":"10.1073\/pnas.1405484111","article-title":"Medically important differences in snake venom composition are dictated by distinct postgenomic mechanisms","volume":"111","author":"Casewell","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.molimm.2023.12.006_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1051\/jbio\/2009043","article-title":"Guidelines for the production, control and regulation of snake antivenom immunoglobulins","volume":"204","author":"Chippaux","year":"2010","journal-title":"Biologie aujourd\u2019hui"},{"key":"10.1016\/j.molimm.2023.12.006_bib13","first-page":"120","article-title":"Comparative stabilities in vitro and in vivo of a recombinant mouse antibody FvCys fragment and a bisFvCys conjugate","volume":"149","author":"Cumber","year":"1992","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.molimm.2023.12.006_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/bcp.12739","article-title":"Adverse reactions to snake antivenom, and their prevention and treatment: Adverse reactions to snake antivenom, and their prevention and treatment","volume":"81","author":"de Silva","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.molimm.2023.12.006_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000435","article-title":"Low-Dose Adrenaline, Promethazine, and Hydrocortisone in the Prevention of Acute Adverse Reactions to Antivenom following Snakebite: A Randomised, Double-Blind, Placebo-Controlled Trial","volume":"8","author":"de Silva","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.molimm.2023.12.006_bib16","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1021\/cr200085w","article-title":"Phospholipase A 2 Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention","volume":"111","author":"Dennis","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.molimm.2023.12.006_bib17","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/00005072-199612000-00006","article-title":"Myotoxic activity of the toxic phospholipase, notexin, from the venom of the Australian tiger snake","volume":"55","author":"Dixon","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.molimm.2023.12.006_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/1472-6750-9-61","article-title":"Simple and efficient site-directed mutagenesis using two single-primer reactions in parallel to generate mutants for protein structure-function studies","volume":"9","author":"Edelheit","year":"2009","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.molimm.2023.12.006_bib19","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jprot.2011.03.026","article-title":"Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases","volume":"74","author":"Escalante","year":"2011","journal-title":"J. Proteom."},{"key":"10.1016\/j.molimm.2023.12.006_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.toxicon.2021.04.017","article-title":"Development and characterization of human single chain antibody against Iranian Macrovipera lebetina snake venom","volume":"197","author":"Eskafi","year":"2021","journal-title":"Toxicon . J. Int. Soc. Toxinology"},{"key":"10.1016\/j.molimm.2023.12.006_bib21","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1111\/febs.12386","article-title":"Muscle phospholipid hydrolysis by Bothrops asper Asp49 and Lys49 phospholipase A 2 myotoxins - distinct mechanisms of action","volume":"280","author":"Fern\u00e1ndez","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.molimm.2023.12.006_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/toxins8100304","article-title":"A Comprehensive View of the Structural and Functional Alterations of Extracellular Matrix by Snake Venom Metalloproteinases (SVMPs): Novel Perspectives on the Pathophysiology of Envenoming","volume":"8","author":"Guti\u00e9rrez","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.molimm.2023.12.006_bib23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.toxicon.2003.11.005","article-title":"Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity","volume":"42","author":"Guti\u00e9rrez","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.molimm.2023.12.006_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.toxicon.2012.09.006","article-title":"Phospholipases A2: Unveiling the secrets of a functionally versatile group of snake venom toxins","volume":"62","author":"Guti\u00e9rrez","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.molimm.2023.12.006_bib25","article-title":"Snakebite envenoming","volume":"3","author":"Guti\u00e9rrez","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.molimm.2023.12.006_bib26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0006-3495(88)82972-2","article-title":"Mild pressure induces resistance of erythrocytes to hemolysis by snake venom phospholipase A2","volume":"54","author":"Halle","year":"1988","journal-title":"Biophys. J."},{"key":"10.1016\/j.molimm.2023.12.006_bib27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/mabs.2.3.11641","article-title":"The immunogenicity of humanized and fully human antibodies","volume":"2","author":"Harding","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.molimm.2023.12.006_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005969","article-title":"Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa","volume":"11","author":"Harrison","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2023.12.006_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrd892","article-title":"The druggable genome","volume":"1","author":"Hopkins","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.molimm.2023.12.006_bib30","series-title":"Small Molecule \u2014 Protein Interactions","first-page":"11","article-title":"Target Analysis: A Priori Assessment of Druggability","author":"Hopkins","year":"2003"},{"key":"10.1016\/j.molimm.2023.12.006_bib31","unstructured":"Horn, D.M., Ueckert, T., Fritzemeier, K., Tham, K., Paschke, C., Berg, F., Pfaff, H., Jiang, X., Li, S., Lopez-Ferrer, D., 2016. New Method for Label-Free Quantification in the Proteome Discoverer Framework. Sunnyvale CA Thermo Fish. Sci."},{"key":"10.1016\/j.molimm.2023.12.006_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.molimm.2022.10.012","article-title":"Antibody multispecificity: A necessary evil?","volume":"152","author":"Jaiswal","year":"2022","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2023.12.006_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14712598.6.1.1","article-title":"Protein therapeutics \u2013 lessons learned and a view of the future","volume":"6","author":"Johnson-L\u00e9ger","year":"2006","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.molimm.2023.12.006_bib34","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1111\/j.1742-4658.2011.08115.x","article-title":"Enzymatic toxins from snake venom: structural characterization and mechanism of catalysis: Enzymatic toxins from snake venom","volume":"278","author":"Kang","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.molimm.2023.12.006_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050218","article-title":"The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and Deaths","volume":"5","author":"Kasturiratne","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.molimm.2023.12.006_bib36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.abb9303","article-title":"Convergent evolution of pain-inducing defensive venom components in spitting cobras","volume":"371","author":"Kazandjian","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.molimm.2023.12.006_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.toxicon.2019.10.006","article-title":"Development of a human scFv antibody targeting the lethal Iranian cobra (Naja oxiana) snake venom","volume":"171","author":"Kazemi-Lomedasht","year":"2019","journal-title":"Toxicon . J. Int. Soc. Toxinology"},{"key":"10.1016\/j.molimm.2023.12.006_bib38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/toxins8100284","article-title":"Metalloproteases affecting blood coagulation, fibrinolysis and platelet aggregation from snake venoms: definition and nomenclature of interaction sites","volume":"8","author":"Kini","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.molimm.2023.12.006_bib39","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3390\/toxins10120534","article-title":"Biosynthetic Oligoclonal Antivenom (BOA) for snakebite and next-generation treatments for snakebite victims","volume":"10","author":"Kini","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.molimm.2023.12.006_bib40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/toxins12090528","article-title":"Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy","volume":"12","author":"Knudsen","year":"2020","journal-title":"Toxins"},{"key":"10.1016\/j.molimm.2023.12.006_bib41","unstructured":"Lapid, C., and Y. Gao. \"PrimerX-Automated design of mutagenic primers for site-directed mutagenesis.\" (2003)."},{"key":"10.1016\/j.molimm.2023.12.006_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxicon.2015.07.334","article-title":"Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score","volume":"104","author":"Laustsen","year":"2015","journal-title":"Toxicon . J. Int. Soc. Toxinology"},{"key":"10.1016\/j.molimm.2023.12.006_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.toxicon.2016.12.010","article-title":"Pitfalls to avoid when using phage display for snake toxins","volume":"126","author":"Laustsen","year":"2017","journal-title":"Toxicon"},{"key":"10.1016\/j.molimm.2023.12.006_bib44","article-title":"In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies","volume":"9","author":"Laustsen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2023.12.006_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.toxicon.2018.03.004","article-title":"Pros and cons of different therapeutic antibody formats for recombinant antivenom development","volume":"146","author":"Laustsen","year":"2018","journal-title":"Toxicon"},{"key":"10.1016\/j.molimm.2023.12.006_bib46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/toxins10060236","article-title":"Basics of Antibody Phage Display Technology","volume":"10","author":"Ledsgaard","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.molimm.2023.12.006_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36393-4","article-title":"Discovery and optimization of a broadly-neutralizing human monoclonal antibody against long-chain \u03b1-neurotoxins from snakes","volume":"14","author":"Ledsgaard","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2023.12.006_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2022.2085536","article-title":"In vitro discovery of a human monoclonal antibody that neutralizes lethality of cobra snake venom","volume":"14","author":"Ledsgaard","year":"2022","journal-title":"mAbs"},{"key":"10.1016\/j.molimm.2023.12.006_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/AEM.02608-15","article-title":"Antibodies against Venom of the Snake Deinagkistrodon acutus","volume":"82","author":"Lee","year":"2016","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.molimm.2023.12.006_bib50","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/toxins9110347","article-title":"Single Chain Antibody Fragment against Venom from the Snake Daboia russelii formosensis","volume":"9","author":"Lee","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.molimm.2023.12.006_bib51","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/toxins10100380","article-title":"Delayed Oral LY333013 Rescues Mice from Highly Neurotoxic, Lethal Doses of Papuan Taipan (Oxyuranus scutellatus) Venom","volume":"10","author":"Lewin","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.molimm.2023.12.006_bib52","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1111\/bph.15178","article-title":"ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020","volume":"177","author":"Lilley","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.molimm.2023.12.006_bib53","article-title":"Improvement of antibody functionality by structure-guided paratope engraftment","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molimm.2023.12.006_bib54","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.toxicon.2012.02.007","article-title":"Snake venom Lys49 myotoxins: From phospholipases A2 to non-enzymatic membrane disruptors","volume":"60","author":"Lomonte","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.molimm.2023.12.006_bib55","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/pro.3263","article-title":"A multispecific monoclonal antibody G2 recognizes at least three completely different epitope sequences with high affinity","volume":"26","author":"Mahmud","year":"2017","journal-title":"Protein Sci."},{"key":"10.1016\/j.molimm.2023.12.006_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001018","article-title":"Snakebite Mortality in India: A Nationally Representative Mortality Survey","volume":"5","author":"Mohapatra","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2023.12.006_bib57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/antib2020193","article-title":"In Vivo Applications of Single Chain Fv (Variable Domain) (scFv) Fragments","volume":"2","author":"Monnier","year":"2013","journal-title":"Antibodies"},{"key":"10.1016\/j.molimm.2023.12.006_bib58","first-page":"16","article-title":"Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action","volume":"65","author":"Montecucco","year":"2008"},{"key":"10.1016\/j.molimm.2023.12.006_bib59","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/toxins10110474","article-title":"Snake venom peptides: tools of biodiscovery","volume":"10","author":"Munawar","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.molimm.2023.12.006_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4161\/mabs.2.1.10786","article-title":"Antibody fragments: hope and hype","volume":"2","author":"Nelson","year":"2010","journal-title":"mAbs"},{"key":"10.1016\/j.molimm.2023.12.006_bib61","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41570-022-00393-7","article-title":"The chemistry of snake venom and its medicinal potential","volume":"6","author":"Oliveira","year":"2022","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.molimm.2023.12.006_bib62","article-title":"Snake Venomics of African Spitting Cobras: Toxin Composition and Assessment of Congeneric Cross-Reactivity of the Pan-African EchiTAb-Plus-ICP Antivenom by Antivenomics and Neutralization Approaches [WWW Document]","author":"Petras","year":"2011","journal-title":"ACS Publ."},{"key":"10.1016\/j.molimm.2023.12.006_bib63","first-page":"71","article-title":"Management of snake-bite in rural Maharashtra: a 10-year experience","volume":"18","author":"Punde","year":"2005","journal-title":"Natl. Med. J. India"},{"key":"10.1016\/j.molimm.2023.12.006_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.toxicon.2014.11.001","article-title":"Phage display as a novel promising antivenom therapy: A review","volume":"93","author":"Roncolato","year":"2015","journal-title":"Toxicon"},{"key":"10.1016\/j.molimm.2023.12.006_bib65","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nprot.2011.448","article-title":"Expression of high-affinity human antibody fragments in bacteria","volume":"7","author":"Rouet","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.molimm.2023.12.006_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008596","article-title":"Echis carinatus snake venom metalloprotease-induced toxicities in mice: Therapeutic intervention by a repurposed drug, Tetraethyl thiuram disulfide (Disulfiram)","volume":"15","author":"Rudresha","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2023.12.006_bib67","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1745-7254.2005.00135.x","article-title":"Antibody engineering: facing new challenges in cancer therapy","volume":"26","author":"Sanz","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.molimm.2023.12.006_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007899","article-title":"Beyond the \u2018big four\u2019: Venom profiling of the medically important yet neglected Indian snakes reveals disturbing antivenom deficiencies","volume":"13","author":"Senji Laxme","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2023.12.006_bib69","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0958-1669(00)00152-X","article-title":"Phage display in pharmaceutical biotechnology","volume":"11","author":"Sidhu","year":"2000","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.molimm.2023.12.006_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005172","article-title":"Clinical and Pharmacological Investigation of Myotoxicity in Sri Lankan Russell\u2019s Viper (Daboia russelii) Envenoming","volume":"10","author":"Silva","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2023.12.006_bib71","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.actatropica.2017.09.001","article-title":"Discovery of human scFvs that cross-neutralize the toxic effects of B. jararacussu and C. d. terrificus venoms","volume":"177","author":"Silva","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.molimm.2023.12.006_bib72","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1303645110","article-title":"Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency","volume":"110","author":"Tharakaraman","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.molimm.2023.12.006_bib73","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nbt.3040","article-title":"Biopharmaceutical benchmarks 2014","volume":"32","author":"Walsh","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molimm.2023.12.006_bib74","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3390\/molecules23020391","article-title":"Exploration of the inhibitory potential of varespladib for snakebite envenomation","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.molimm.2023.12.006_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122586","article-title":"Erythrocyte haemotoxicity profiling of snake venom toxins after nanofractionation","volume":"1176","author":"Xie","year":"2021","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life. Sci."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589023002456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589023002456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:52:37Z","timestamp":1777492357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589023002456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":75,"alternative-id":["S0161589023002456"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2023.12.006","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant human scFv antibody fragments against phospholipase A2 from Naja naja and Echis carinatus snake venoms: In vivo neutralization and mechanistic insights","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2023.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}